Headlines

US BROKER MOVES: CSGP upgraded at Jefferies; WMT downgraded at HSBC

Newsquawk Staff ·

UPGRADES

  • YETI Holdings (YETI) upgraded from Neutral to Buy at B Riley; PT USD 54
  • Southern Co (SO) upgraded from Underweight to Equal-Weight at Wells Fargo; PT USD 96
  • Southern Co (SO) upgraded from Neutral to Outperform at Mizuho Securities; PT USD 104
  • Neptune Insurance (NP) upgraded from Underperform to Neutral at BofA; PT USD 23
  • Healthcare Services (HCSG) upgraded from Market Perform to Outperform at William Blair
  • Group 1 Automotive (GPI) upgraded from Neutral to Overweight at JPMorgan; PT USD 370
  • Etsy (ETSY) upgraded from Equalweight to Overweight at Barclays
  • CoStar (CSGP) upgraded from Hold to Buy at Jefferies; PT USD 67

DOWNGRADES

  • Walmart (WMT) downgraded from Buy to Hold at HSBC; PT USD 131
  • Teekay Tankers (TNK) downgraded from Buy to Hold at DNB Carnegie
  • TechnipFMC (FTI) downgraded from Buy to Hold at HSBC; PT USD 62
  • Reliance (RS) downgraded from Overweight to Neutral at JPMorgan; PT USD 330
  • Reliance (RS) downgraded from Outperform to Market Perform at BMO; PT USD 320
  • Molina (MOH) downgraded from Overweight to Equal-Weight at Wells Fargo; PT USD 141
  • Mister Car Wash (MCW) downgraded from Outperform to Market Perform at Raymond James
  • Coeur Mining (CDE) downgraded from Buy to Hold at Canaccord
  • BorgWarner (BWA) downgraded from Neutral to Sell at UBS; PT USD 55
  • Alight (ALIT) downgraded from Buy to Neutral at Citi; PT USD 1

INITIATIONS

  • Terra Innovatum Global (NKLR) initiated at Buy at Canaccord; PT USD 10
  • Satellogic (SATL) initiated at Overweight at Cantor; PT USD 7
  • Pfizer (PFE) initiated at Underweight at Barclays
  • Okyo Pharma (OKYO) initiated at Overweight at Piper Sandler; PT USD 7
  • Merck & Co (MRK) initiated at Overweight at Barclays
  • Gilead (GILD) initiated at Equal-Weight at Barclays
  • General Electric Aerospace (GE) initiated at Overweight at Morgan Stanley; PT USD 425
  • Eli Lilly (LLY) initiated at Overweight at Barclays
  • Dauch Corp. (DCH) initiated at Buy at Jefferies; PT USD 10.35
  • Bristol Myers (BMY) initiated at Overweight at Barclays
  • Biogen (BIIB) initiated at Equal-Weight at Barclays
  • Beam Therapeutics (BEAM) initiated at Buy at Canaccord; PT USD 74
  • Affirm Holdings (AFRM) initiated at Neutral at Baird; PT USD 55
  • AbbVie (ABBV) initiated at Overweight at Barclays

What it means

The upgrades and downgrades from major brokers highlight shifting sentiments in the market, particularly with CoStar Group seeing a favorable upgrade to "Buy" while Walmart faces a downgrade to "Hold". This divergence signals potential buying interest in real estate services amid caution in the retail sector, which may reflect concerns about consumer spending. Overall, keep an eye on sector momentum as these recommendations could influence trading strategies moving forward.

Related headlines